Login / Signup
Piers Gillett
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Clinical Trial
Double Blind
Phase Ii
Squamous Cell
Top Venues
Cost effectiveness and resource allocation : C/E
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Piers Gillett
,
Robert K Mahar
,
Nancy R Tran
,
Mark Rosenthal
,
Maarten J IJzerman
Developing and validating a multi-criteria decision analytic tool to assess the value of cancer clinical trials: evaluating cancer clinical trial value.
Cost effectiveness and resource allocation : C/E
21 (1) (2023)